放射学实践
放射學實踐
방사학실천
RADIOLOGIC PRACTICE
2014年
7期
791-794
,共4页
王宗盛%顾艳%袁刚%黄连庆%周胜利
王宗盛%顧豔%袁剛%黃連慶%週勝利
왕종성%고염%원강%황련경%주성리
孤立性肺结节%体层摄影术,X线计算机%灌注成像%微血管密度
孤立性肺結節%體層攝影術,X線計算機%灌註成像%微血管密度
고립성폐결절%체층섭영술,X선계산궤%관주성상%미혈관밀도
Solitary pulmonary nodules%Tomography,X-ray computed%Perfusion imaging%Microvessel density
目的:探讨肺部孤立性病变多层螺旋CT (MSCT )灌注成像参数与肿瘤微血管密度(MVD )间的关系,评价MSCT灌注成像对肺部孤立性病变的鉴别诊断价值。方法:80例经病理证实的肺部孤立性病变患者行 MSCT 灌注成像检查,计算血流量(BF)、血容量(BV)、平均通过时间(MTT)、毛细血管通透性(PS);采用CD34单抗标记测定 MVD,分析良、恶性病变、炎性病变、不同分化程度肿瘤组织的CT灌注参数差异及各参数与 MVD间的相关性。结果:良、恶性和炎性病变组的BV分别为(3.45±1.75)、(10.40±4.08)、(8.40±8.42)mL/100g;BF 分别为(24.48±18.74)、(77.75±43.03)、(84.54±107.13)mL/(100g·min);PS分别为(4.33±2.90)、(21.70±10.86)、(14.67±10.29)mL/(100g·min);MTT分别为(15.54±7.01)、(15.23±13.35)、(12.55±8.39)s。良性组与恶性组、良性组与炎性组BF、BV、PS值差异均具有统计学意义(P<0.05);恶性组与炎性组间仅 PS 差异具有统计学意义(P<0.05),MTT 均无相关性(P>0.05)。MVD在非小细胞肺癌不同分化程度鉴别方面具有统计学意义。BF、BV、PS与 MVD呈正相关(P<0.05),MTT与 MVD无相关性(P>0.05)。结论:MSCT灌注成像可间接反映活体肺部孤立性病变血管生成情况,为鉴别肺部孤立性病变良恶性和治疗、预后评估提供依据。
目的:探討肺部孤立性病變多層螺鏇CT (MSCT )灌註成像參數與腫瘤微血管密度(MVD )間的關繫,評價MSCT灌註成像對肺部孤立性病變的鑒彆診斷價值。方法:80例經病理證實的肺部孤立性病變患者行 MSCT 灌註成像檢查,計算血流量(BF)、血容量(BV)、平均通過時間(MTT)、毛細血管通透性(PS);採用CD34單抗標記測定 MVD,分析良、噁性病變、炎性病變、不同分化程度腫瘤組織的CT灌註參數差異及各參數與 MVD間的相關性。結果:良、噁性和炎性病變組的BV分彆為(3.45±1.75)、(10.40±4.08)、(8.40±8.42)mL/100g;BF 分彆為(24.48±18.74)、(77.75±43.03)、(84.54±107.13)mL/(100g·min);PS分彆為(4.33±2.90)、(21.70±10.86)、(14.67±10.29)mL/(100g·min);MTT分彆為(15.54±7.01)、(15.23±13.35)、(12.55±8.39)s。良性組與噁性組、良性組與炎性組BF、BV、PS值差異均具有統計學意義(P<0.05);噁性組與炎性組間僅 PS 差異具有統計學意義(P<0.05),MTT 均無相關性(P>0.05)。MVD在非小細胞肺癌不同分化程度鑒彆方麵具有統計學意義。BF、BV、PS與 MVD呈正相關(P<0.05),MTT與 MVD無相關性(P>0.05)。結論:MSCT灌註成像可間接反映活體肺部孤立性病變血管生成情況,為鑒彆肺部孤立性病變良噁性和治療、預後評估提供依據。
목적:탐토폐부고립성병변다층라선CT (MSCT )관주성상삼수여종류미혈관밀도(MVD )간적관계,평개MSCT관주성상대폐부고립성병변적감별진단개치。방법:80례경병리증실적폐부고립성병변환자행 MSCT 관주성상검사,계산혈류량(BF)、혈용량(BV)、평균통과시간(MTT)、모세혈관통투성(PS);채용CD34단항표기측정 MVD,분석량、악성병변、염성병변、불동분화정도종류조직적CT관주삼수차이급각삼수여 MVD간적상관성。결과:량、악성화염성병변조적BV분별위(3.45±1.75)、(10.40±4.08)、(8.40±8.42)mL/100g;BF 분별위(24.48±18.74)、(77.75±43.03)、(84.54±107.13)mL/(100g·min);PS분별위(4.33±2.90)、(21.70±10.86)、(14.67±10.29)mL/(100g·min);MTT분별위(15.54±7.01)、(15.23±13.35)、(12.55±8.39)s。량성조여악성조、량성조여염성조BF、BV、PS치차이균구유통계학의의(P<0.05);악성조여염성조간부 PS 차이구유통계학의의(P<0.05),MTT 균무상관성(P>0.05)。MVD재비소세포폐암불동분화정도감별방면구유통계학의의。BF、BV、PS여 MVD정정상관(P<0.05),MTT여 MVD무상관성(P>0.05)。결론:MSCT관주성상가간접반영활체폐부고립성병변혈관생성정황,위감별폐부고립성병변량악성화치료、예후평고제공의거。
Objective:To observe the correlation between MSCT perfusion parameters and microvessel density (MVD),and to evaluate the diagnostic value of CT perfusion in differentiating the solitary pulmonary lesions.Methods:80 cases of solitary pulmonary lesions proved by pathology underwent CT perfusion.Blood flow(BF),blood volume (BV), mean transit time(MTT)and permeability surface(PS)were caculated.To measure the MVD using CD34 labeled mono-clonal antibody.To compare MSCT perfusion parameters between malignant tumors of different grades,benign,malignant and inflammatory lesions.To analyse the correlation between MSCT perfusion parameters and MVD.Results:The BF value of benign,malignant and inflammatory lesions was (3.45± 1.75)、(10.40±4.08)、(8.40±8.42)mL/100g,respectively;the BV value was (24.48±18.74)、(77.75±43.03)、(84.54±107.13)mL/(100g·min),respectively;the PS value was (4.33±2.90)、(21.70±10.86)、(14.67±10.29)mL/(100g·min),respectively;the MTT value was (15.54±7.01)、(15.23±13.35)、(12.55±8.39)s,respectively;The differences of BF,BV,PS between benign and malignant lesions,be-nign and inflammatory lesions were statistically significant(P<0.05).Only the difference of PS between malignant and in-flammatory lesions was statistically significant(P<0.05).There were no significant differences in MTT between the three groups (P>0.05).There was statistically difference in MVD between different grades of non-small cell lung cancer (P<0.05).BF、BV、PS were positive correlated with MVD (r= 0.316,0.886,0.617,P<0.05).There was no correlation be-tween MTT and MVD (P>0.05).Conclusion:MSCT perfusion can reflected the angiogenesis of solitary pulmonary lesions in vivo inderectly,and can provide evidences for the differential diagnosis,optimization of a reasonable treatment protocol, the evaluation of curative effect and the prognosis.